CaMKK2 Identifies Biologically Aggressive Chronic Lymphocytic Leukemia and Regulates Leukemic Survival and Nurse-Like Cell Support
Shekeab Jauhari, Alicia D. Volkheimer, Vini Verma, Dilber Gökçe Kaplan, Fahmin Basher, Joe Brice Weinberg, Nelson Jen An Chao, Luigi Racioppi
This paper identifies CaMKK2 as a prognostic biomarker for aggressive chronic lymphocytic leukemia and shows its functional role in leukemic survival and nurse-like cell support.
bioRxiv · Feb 24, 2026 · PreprintImmunology